By Tony Fong
NEW YORK (GenomeWeb News) – Having demonstrated the utility of its technology, molecular diagnostics firm Sequenta will focus on clinical validation of its technology in 2012 with an expected launch of its first product next year.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.
A technology that has the potential to make species go extinct could be used against the Zika virus.
University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.
If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?
This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.
This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.